true

Drug Delivery Systems

Committed to drug delivery excellence. Our vision is to enable customer success with high quality and innovative drug delivery solutions that improve patient well-being.

Products

Introducing Drug Delivery Systems

Innovative design, global manufacturing, product development expertise

With over 50 years of experience, we are empowering customer success through innovative drug-delivery solutions that improve patient quality of life.

At a glance…

>3Bn

Prefillable Syringes* (PFS) manufactured per year¹
$2Bn

Yearly revenue (2022)**
7500

Associates globally
8

Manufacturing plants worldwide
Global Headquarters

in Pont-de-Claix, France

Products used by more than 500 Pharmaceutical and Biotechnology companies.²

BD customers include 27 of the top 30 pharmaceutical companies in the world.³

~70% of the top 100 pharmaceutical companies around the world rely BD Medical-Pharmaceutical Systems prefillable drug-delivery systems for a wide variety of therapeutic applications.⁴

BD has generated over 4000 patents that are enforced in more than 25 countries.⁵

Explore more about manufacturing

We are focusing on patient well-being

There is a patient at the end of each of the billions of drug delivery devices that we make at BD. That is why we have invested in deep knowledge around patient experience, injection science and combination product development to anticipate customer challenges, manage complexities, and reduce risks. We also invest heavily to support our commitment to quality. Through our extensive global manufacturing network, we aim to offer security of supply and business continuity to our customers.

These, plus our ability to leverage the industry and health authority partnerships of a global healthcare company, are game changing advantages that BD brings to our customers’ drug delivery challenges.

We leverage these assets as we develop innovative solutions that provide peace of mind to customers and contribute to greater patient well-being.

BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.

Explore more about our products

Prefillable syringe systems

Featuring a comprehensive portfolio of innovative prefillable syringe systems, BD offers drug delivery solutions designed to help decrease development risk, improve speed to market, and increase flexibility to meet patients’ needs across a wide range of drug types and therapeutic areas.

Explore our prefillable syringes

Safety and shielding systems

BD Safety & Shielding Systems provide pharmaceutical companies with a wide range of both active and passive manual injection solutions available in 0.5ml, 1ml, and 2.25ml formats, suitable for a variety therapeutic indications.

Explore our safety and shielding devices

Self-injection systems

BD offers an extensive portfolio of patient centric, self-administered drug delivery solutions including disposable autoinjectors, disposable variable dose pen injectors, and wearable injectors designed to deliver a wide range of volumes and viscosities and help de-risk combination product development.

Explore our self-injection systems

Add ons and components

To fulfill our system approach, we provide a complete set of components for your prefillable syringe systems.

Explore our add ons and components

A history of innovation and market leadership

Honors and Recognition

* PFS containers

** BD Annual report 2022

BDM-PS Financial file November 2022, “Actual FY22” Permiter.
BDM-PS Financial file November 2020, "Actual FY20" Permiter.
BD Customers compared to Evaluate Pharma ranking FY2019
IQVIA: IQVIA dataset extracted on March 11th, 2021, from the IQVIA Smart MIDAS' on-line platform, includes WW sales of injectable drugs. Top 100 Corporation (based on IQVIA standard units 2020) selling PFS, Autoinjectors or Pens. TA included: Acute biologics, Anticoagulants, Chronic, Small molecules, Vaccines
BDM-PS Patents – In force – Worldwide – October 2021.

BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.

Prefillable syringe systems

Explore our prefillable syringes

Safety and shielding systems

Explore our safety and shielding devices

Self-injection systems

Explore our self injection systems

Add ons and components

To fulfill our system approach, we provide a complete set of components for your prefillable syringe systems.

Explore our add ons and components

Services and Solutions

BD understands the drug development process and objectives at each stage and offers a wide range of services to help develop container/device strategy and life cycle management plan for drugs.

Services

BD Pharmaceutical Services and Solutions are designed to help you achieve your combination product goals, from development to launch.

Explore our services

BD PartnerPath program™

BD PartnerPath program™ supports the development of combination products, with quick access to small quantities of preconfigured drug delivery systems.

Learn more on BD PartnerPath™ program

Capabilities

We’ve built our services and capabilities around a deep understanding of the combination product development process and the key objectives at each stage, from discovery to delivery.

We are committed to partnering for your sustained commercial success.

System Integration

Effective system integration can be critical to the success of combination products for pharmaceutical companies.¹

Explore our system integration

Manufacturing excellence

We manufacture our solutions with a strict focus on continuously advancing quality, consistency and capacity.

Explore our manufacturing

Quality

Quality is the foundation of customer and patient trust; it is at the core of what we do to provide safe, effective products and services. All BD associates are committed to a culture of quality inspired by the customers and patients we serve.

Explore our quality

Market Research “Challenges with System Integration" [external study], Franklin Lakes, NJ, USA: GLG 2019

Biologic Drugs

View documents

Hospital Treatments

View documents

Vaccines

View documents

Specialty Pharmaceuticals

View documents

View research articles published in a journal and written by experts sharing study results that offer you insight into a particular topic.

Learn more

View a scientific poster, such as those used for display at BD tradeshows or seminars to provide detailed information on a research topic

Learn more

Understand BD Products and services.

Learn more

Learn more about order details, product specs, and technical information by viewing a brochure

Learn more

Visit the BD Medical - Pharmaceutical Systems webinar portal

Learn more

Watch a video to be educated about BD products or services

Learn more

View promotions or announcements for BD products and services

Learn more

Join BD at DCAT Week 2025, from March 17-20 in New York City. Here’s what you can expect:

BD Latest Developments
Networking Opportunities
BD Interactive Sessions
BD Current Solutions

Learn more

Jan 22-23 - Hall 7.2, Booth E55 - Paris Expo, Porte de Versailles

Jan. 22 - 15:15 – 🎤 Keynote
Jan. 22 - 15:50 – 🧪 Presentation
Jan. 22 - 16:05 – 🗣️ Panel Discussion
Jan. 23- 10:50 – 📊 Presentation

Learn more

October 28-29

BD Presentations

Solo Talk: October 28 from 12:15PM to 12:30PM ET
Tech Talk

Boston, Massachusetts - USA

Learn more

October 22-23

2 BD Presentations

Tech Talk: Wednesday, October 23 from 9:25AM to 9:35AM
Podium presentation: Wednesday, October 23 from 13:55PM to 14:15PM

Phoenix, Arizona - USA

Learn more

October 8-10

Live Demos & Photo Booth

Frankfurt - Germany

Learn more

June 10-14

Thursday June 13 from 10:30 to 11:00AM

Frankfurt - Germany

Learn more

June 4-5

From 9:00 to 10:30AM

Antwerp (Belgium)

Learn more

March 26 4:45pm - 6:15pm CDT

Salon C

Hilton Chicago Hotel – Chicago, IL

Learn more

California, USA

February 28 - 29, 2024

DoubleTree Hilton Anaheim Resort

Learn more

February 7th, 2024 at 3:05pm EDT

Boston - USA

Learn more

Porte de Versailles

January 24-25, 2024

Hall 7.2 – BD Booth E60

Learn more

Sep 13, 2022

BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency

BD Effivax™ Glass Prefillable Syringe Features Enhanced Technology that Builds on Company’s Decades of Expertise in the Prefillable Syringe Market and Supports Customers’ Manufacturing Needs FRANKLIN LAKES, N.J. (September 13, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.1
May 18, 2022

BD and Mitsubishi Gas Chemical have signed a letter of intent (LOI) to discuss a partnership agreement to explore

Companies to work together with the aim of optimizing advanced technologies for use in prefillable syringes FRANKLIN LAKES, N.J. (May 18, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented chemical manufacturer based in Tokyo, Japan, today announced that they have entered into an agreement to investigate further development of OXYCAPT™ - an innovation from MGC that integrates the best of plastic and glass for plastic syringes.

Access to small quantities of preconfigured BD product >>

true

Drug Delivery Systems

We are focusing on patient well-being

A history of innovation and market leadership

1996

1990

1975

1954

2022

2021

2021

2021

2021

2019

2018

2018

2014

2013

2013

2013

2012

2012

2011

2010

2009

2004

2003

2001

2000

2000

1998

1998

1996

1996

1990

1975

1954

2022

2021

2021

2021

2018 – iF Design

2015 – Thomson Reuters

2015 – PDMA OCI

2015 – Fortune

2022 - Ease of Use℠ Award

2021 – Vaccine Industry Excellence

2021 – Frost & Sullivan

2020 – Derwent

2019 – Good Design® Award

2018 – iF Design

2015 – Thomson Reuters

2015 – PDMA OCI

2015 – Fortune

2022 - Ease of Use℠ Award

2021 – Vaccine Industry Excellence

2021 – Frost & Sullivan

2020 – Derwent

Let’s have a conversation.

Biologic Drugs

Hospital Treatments

Vaccines

Specialty Pharmaceuticals